Point-of-Care Program Increases Prostate Cancer Genetic Testing
Researchers pioneered and implemented a novel algorithm to provide genetic testing to patients with newly diagnosed prostate cancer.
Read MorePosted by Andy Lundin | Dec 15, 2022 | Prostate |
Researchers pioneered and implemented a novel algorithm to provide genetic testing to patients with newly diagnosed prostate cancer.
Read MorePosted by Chris Wolski | Dec 15, 2022 | Covid 19 |
Roche has entered into a U.S. focused collaboration with Pfizer to drive awareness and educate on the importance of timely COVID-19 testing.
Read MorePosted by Chris Wolski | Dec 1, 2022 | Flu & Respiratory Infections, Molecular Diagnostics |
Syndromic testing provides labs flexibility, maximizes equipment and personnel resources, and helps control costs.
Read MorePosted by Andy Lundin | Nov 28, 2022 | Sexually Transmitted Diseases |
Chembio announced the submission to the FDA for a Clinical Laboratory Improvement Amendments waiver for the DPP HIV-Syphilis System.
Read MorePosted by Andy Lundin | Nov 23, 2022 | Emerging & Zoonotic Diseases |
Qiagen launched a monkeypox test for its NeuMoDx automated PCR platform to strengthen surveillance and research into the current outbreak.
Read More